ILMN up +1.69% percent Today $ILMN High is at 190.18 and

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
ILMN up +1.69% percent Today $ILMN High is at 190.18 and the Low 186.31 with current volume of 498,804.

Recent News posted below.

Illumina Inc ILMN other info.
http://investorshangout.com/Illumina-ILMN-54443/

ILMN Illumina Inc Recent Headline News

A/D Rating Helps Spot What The Pros Are Buying
at Investor's Business Daily - Thu Nov 06, 5:41PM CST
If you're prepping a small patch of land, a shovel and a hoe from Home Depot (HD) will suffice. But if you have acres to dig up, then you'll need industrial-size earth-moving equipment. In the stock market, it takes big money from professional...
BCC: 36.58 (-0.85), HD: 97.66 (+0.01), AKRX: 35.06 (-1.53), ILMN: 188.90 (+2.55)

'Mad Money' Lightning Round: Pull the Trigger on Baxter
at The Street - Thu Nov 06, 5:00AM CST
Cramer likes Illumina but isn't a big fan of GEO Group or AK Steel Holdings.
RIG: 29.36 (-0.35), GEO: 41.12 (-0.28), TMO: 117.11 (+0.51), ESV: 40.11 (-1.20), NUE: 53.80 (-0.38), BAX: 70.55 (-0.06), ILMN: 188.90 (+2.55), AKS: 6.62 (unch), OXY: 87.68 (-0.36)

Jim Cramer's 'Mad Money' Recap: What a Republican Senate Means for Stocks
at The Street - Wed Nov 05, 7:20PM CST
It's bullish news but you can't buy just anything, Cramer says.
ACT: 247.11 (+1.20), LMT: 187.02 (+0.87), XOM: 96.26 (-0.33), ILMN: 188.90 (+2.55), AKS: 6.62 (unch), KORS: 69.47 (-0.48), PAYX: 47.50 (+0.17), RIG: 29.36 (-0.35), EOG: 98.65 (-0.90), COST: 137.48 (-0.23), TWTR: 40.11 (-0.20), OXY: 87.68 (-0.36), KO: 42.44 (+0.12), SEAS: 18.49 (+0.10), TMO: 117.11 (+0.51), NUE: 53.80 (-0.38), TRIP: 73.12 (-0.53), DISCA: 32.42 (-0.20), CHUY: 23.05 (+1.03), LB: 76.07 (+0.46), GEO: 41.12 (-0.28), ESV: 40.11 (-1.20), MPC: 93.60 (-0.48), BAX: 70.55 (-0.06), MRK: 58.75 (-0.59), EXPE: 86.05 (+0.94), STI: 39.69 (+0.03)

SmarTrend Watching for Potential Rebound in Shares of Illumina After 2.63% Loss
Comtex SmarTrend(R) - Wed Nov 05, 4:33PM CST
Illumina (NASDAQ:ILMN) traded in a range yesterday that spanned from a low of $184.83 to a high of $194.13. Yesterday, the shares fell 2.6%, which took the trading range below the 3-day low of $189.64 on volume of 1.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ILMN: 188.90 (+2.55)

Illumina Falls 2.63% on Heavy Volume: Watch For Potential Rebound
Comtex SmarTrend(R) - Wed Nov 05, 4:33PM CST
Illumina (NASDAQ:ILMN) traded in a range yesterday that spanned from a low of $184.83 to a high of $194.13. Yesterday, the shares fell 2.6%, which took the trading range below the 3-day low of $189.64 on volume of 1.1 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ILMN: 188.90 (+2.55)

Top Funds Buy Ulta Beauty, Alexion, Avago
at Investor's Business Daily - Tue Nov 04, 5:52PM CST
Managers of leading mutual funds in recent months have continued to stock up on large medical stocks, such as Illumina (ILMN), Alexion Pharmaceuticals (ALXN), Celgene (CELG), Jazz Pharmaceuticals (JAZZ),Allergan (AGN) and Centene (CNC). The...
AMBA: 49.01 (+1.87), MNST: 106.69 (-1.70), SWKS: 60.82 (+0.94), GMCR: 155.26 (+2.36), ILMN: 188.90 (+2.55), WSM: 66.49 (+0.61), NXPI: 74.50 (+0.96), CELG: 107.74 (+1.29), HAIN: 108.78 (+1.10), AGN: 195.77 (-0.23), CNC: 92.79 (+1.07), V: 250.18 (-2.25), CALM: 42.52 (-0.51), JAZZ: 171.44 (+0.64), ALXN: 194.19 (+0.38), LOW: 57.92 (+0.23), ULTA: 122.35 (+0.60), MA: 84.87 (+0.07), AVGO: 85.53 (+0.49), PETM: 72.74 (+0.20)

Quarterly Financial Results and Product Approval - Research Reports on Pacira, PAREXEL, WellPoint, Illumina and St. Jude Medical
PR Newswire - Tue Nov 04, 8:00AM CST
Today, Analysts Review released its research reports regarding Pacira Pharmaceuticals Inc. (NASDAQ: PCRX), PAREXEL International Corporation (NASDAQ: PRXL), WellPoint Inc. (NYSE: WLP), Illumina, Inc. (NASDAQ: ILMN) and St. Jude Medical, Inc. (NYSE: STJ). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7670-100free.
PRXL: 54.19 (+0.22), STJ: 65.23 (+0.47), ILMN: 188.90 (+2.55), PCRX: 87.90 (+1.88), WLP: 125.85 (+1.70)

Geron Corporation (GERN) Looks Strong: Stock Up 25.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Nov 04, 7:44AM CST
Geron Corporation (GERN) was a big mover last session, as the company saw its shares surge nearly 26% on the day
MDVN: 110.19 (-2.58), ONCY: 0.82 (+0.12), GERN: 2.25 (-0.08), ILMN: 188.90 (+2.55)

Big Cap 20: Health Care, Tech Stocks Rule The Roost
at Investor's Business Daily - Mon Nov 03, 4:58PM CST
Large-cap stocks often get labeled as boring because of overall sluggish price action, but the latest IBD Big Cap 20 list of leading large-cap growth is far from boring. Recent health care-related names like Alexion Pharmaceuticals (ALXN), Illumina...
LNKD: 227.23 (+4.19), ALXN: 194.19 (+0.38), ILMN: 188.90 (+2.55), REGN: 383.87 (+6.03), CRM: 63.73 (-0.24), CELG: 107.74 (+1.29)

Prosensa Holding N.V. (RNA) Jumps: Stock Moves Up 9.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 8:39AM CST
Prosensa Holding N.V. (RNA) was a big mover last session, as its shares rose nearly 10% on the day.
MDVN: 110.19 (-2.58), MACK: 8.61 (-0.09), RNA: 12.00 (-0.14), ILMN: 188.90 (+2.55)

Alder Biopharmaceuticals (ALDR) Jumps: Stock Rises 6.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 7:51AM CST
Alder Biopharmaceuticals Inc. (ALDR) was a big mover last session, as its shares rose nearly 7% on the day.
MDVN: 110.19 (-2.58), MACK: 8.61 (-0.09), ALDR: 16.67 (+0.10), ILMN: 188.90 (+2.55)

Oncolytics Biotech (ONCY) Looks Strong: Stock Up 21.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 03, 7:44AM CST
Oncolytics Biotech Inc. (ONCY) was a big mover last session, as the company saw its shares surge nearly 22% on the day
MACK: 8.60 (-0.10), MDVN: 110.19 (-2.58), ONCY: 0.82 (+0.12), ILMN: 188.90 (+2.55)

IBD 50 Caps Impressive 2-Week Rally
at Investor's Business Daily - Fri Oct 31, 5:47PM CDT
The IBD 50 just capped its best two-week performance in more than three years -- a run that's produced a batch of breakouts. The index rallied 9.4% over the past two weeks. That's the best two-week period since July 2011, when the IBD 50 roared...
ODFL: 76.87 (+1.75), AAP: 143.77 (+1.92), AKRX: 35.05 (-1.54), ILMN: 188.90 (+2.55), NXPI: 74.55 (+1.01), CDW: 32.87 (+0.28), CELG: 107.74 (+1.29), BIDU: 244.06 (+7.52), GILD: 108.00 (+1.55), JAZZ: 171.43 (+0.63), FLT: 149.19 (+0.01), FL: 54.59 (+0.09), AAPL: 108.89 (-0.12), AVGO: 85.58 (+0.54)

Affymetrix Beats Q3 Earnings & Revenues; Raises '14 View - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 2:30PM CDT
Following the earnings release, shares of Affymetrix Inc. (AFFX) climbed 2.3% to close at $8.30 in the last session.
BIIB: 324.28 (+3.53), ILMN: 188.90 (+2.55), AMAG: 34.61 (-0.34), AFFX: 9.45 (+0.02)

Incyte (INCY) Looks Good: Stock Moves 10.9% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 8:46AM CDT
Incyte (INCY) was a big mover last session, with shares rising nearly 11% on the day.
MDVN: 110.19 (-2.58), BIIB: 324.28 (+3.53), INCY: 69.97 (+0.65), ILMN: 188.90 (+2.55)

Bristol-Myers Squibb (BMY) Jumps: Stock Moves Up 8.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 8:39AM CDT
Bristol-Myers Squibb Company (BMY) was a big mover last session, as its shares rose nearly 9% on the day.
MDVN: 110.19 (-2.58), MACK: 8.60 (-0.10), ILMN: 188.90 (+2.55), BMY: 58.60 (+0.28)

Novo Nordisk A/S (NVO) Shows Strength: Stock Up 6.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Oct 31, 7:51AM CDT
Novo Nordisk A/S (NVO) was a big mover last session, as its shares rose over 6% on the day.
MDVN: 110.19 (-2.58), MACK: 8.60 (-0.10), NVO: 43.31 (-0.38), ILMN: 188.90 (+2.55)

Qiagen Q3 Earnings, Revenues in Line; Outlook Revised - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 1:50PM CDT
Qiagen's (QGEN) strategic collaborations, test menu expansions and moderately balanced international expansion will likely drive growth over time.
BIIB: 324.28 (+3.53), HSKA: 16.01 (+0.11), ILMN: 188.90 (+2.55), QGEN: 23.73 (+0.25)

Cara Therapeutics (CARA) Worth Watching: Stock Rises 6.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 8:39AM CDT
Cara Therapeutics Inc. (CARA) was a big mover last session, as its shares rose over 6% on the day.
MDVN: 110.19 (-2.58), MACK: 8.60 (-0.10), CARA: 8.70 (+0.04), ILMN: 188.90 (+2.55)

Oncolytics Biotech (ONCY) Looks Good: Stock Soars 26% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Oct 30, 8:25AM CDT
Oncolytics Biotech (ONCY) was a big mover last session, with shares surging almost 26% on the day.
MDVN: 110.19 (-2.58), BIIB: 324.28 (+3.53), ONCY: 0.82 (+0.12), ILMN: 188.90 (+2.55)

Illumina Inc. (ILMN) Stock Research Links

ILMN Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 61

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 144

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Air Sealing First: Boosting Home Comfort & Efficiency

Updated Category News Views 69

Everyone wants a cozy, energy-efficient home, right? Well, the first step to achieving that might just surprise you. Forget about shoving more insulation into the walls for a second; air sealing should be your starting line. That's the drum Insulation Expert Mike Mancuso is beating, and he's got a point worth considering before you touch another insulation panel. Cracking...

Continue Reading
ST Engineering iDirect, MBSat Forge Middle East Satellite Hub

Updated Category News Views 181

Satellite Services Take Off in the Middle East Never thought the day would come where the Middle East is on the threshold of leapfrogging satellite tech, but here we are. ST Engineering iDirect just locked arms with MBSat—yep, that's part of the Mohammed Al Barwani Group—to birth a next-gen satellite connectivity service hub in Oman and across surrounding areas....

Continue Reading
Miranda Lambert Lights Up Red Kettle Campaign

Updated Category News Views 28

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 80

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
Innovent's IBI354: New Data Spurs Hope for HER2+ BC

Updated Category News Views 149

Innovent Lauds HER2 ADC's Moment at ESMO 2026 Alright, chin up, investors. At the 2026 ESMO Congress, Innovent's throwing down some promising Phase 2 data for their brainchild, IBI354. You hear that name and it's like hearing about a rock star in the making in the oncology world. The potential here isn’t just talk—it's a loud, resounding call for attention. Their...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 252

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 96

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 331

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

Cisco's Chief Discusses Entry-Level Hiring Trends and AI

Updated Category News Views 192

Cisco's Insights on Entry-Level Hiring Trends The landscape of entry-level job opportunities is seeing a notable shift. Data from an industry student platform reveals a decrease in job postings for recent graduates. The statistics indicate a 16% year-over-year drop in entry-level positions, sparking concern among graduates and job seekers. Understanding the Current Job...

Continue Reading
FMC’s Rimisoxafen: The Game-Changer Amid Weeds' Rebellion

Updated Category News Views 248

FMC's Bold Move in the Herbicide Game Honestly, this takes me back to the dot-com era—not in tech, but in agriculture. FMC Corporation (NYSE:FMC) just pulled a doozy by getting rimisoxafen classified as a dual mode of action herbicide. This baby’s not just a gimmick; it’s a big deal for a sector that's wrestling down weeds like Palmer amaranth that’ve become a...

Continue Reading
Chord Energy Announces Earnings Call for Q2 2025 Results

Updated Category News Views 168

Chord Energy Earnings Release and Conference Call Details Chord Energy Corp. (NASDAQ: CHRD) has exciting news as it gears up to announce its financial and operational results for the second quarter of 2025. This announcement is scheduled to occur after the market closes, on an appointed date that follows the pattern of previous releases. Live Webcast and Conference Call...

Continue Reading
TuniTuni Thrives Globally with Unique Storytelling Approach

Updated Category News Views 338

TuniTuni: A Global Pioneer in Toddler Development TuniTuni is redefining early childhood physical education through its innovative approach that combines storytelling with the essential elements of physical movement. Since its inception in 2003, this leading brand has garnered attention in various regions, particularly emphasizing the importance of physical activity for...

Continue Reading
Investigation into Open Lending Holdings for Investor Losses

Updated Category News Views 363

Investigation into Open Lending Holdings for Investor Losses Faruqi & Faruqi, LLP is taking steps to look into potential claims on behalf of investors who have faced considerable losses related to Open Lending Corporation (NASDAQ: LPRO). If you have experienced financial setbacks from your investments in Open Lending, it’s important to know that you're not alone and...

Continue Reading